SUVENPHAR.BOSUVENPHAR.BOBSE
Loading
Revenue Growth AcceleratingAccelerating
Percentile Rank67
3Y CAGR-23.2%
Studio
Year-over-Year Change

Year-over-year revenue growth rate

3Y CAGR
-23.2%/yr
Annual compound
Percentile
P67
Within normal range
vs 3Y Ago
0.5x
Contraction
Streak
1 yr
Consecutive growthAccelerating
PeriodValue
202513.91%
2024-21.56%
20231.52%
202230.75%
202121.10%
2020-8.05%
20190.00%